MARKET

MNPR

MNPR

Monopar Therapeutics Inc
NASDAQ
60.99
-0.45
-0.73%
After Hours: 60.57 -0.42 -0.69% 19:07 05/14 EDT
OPEN
61.05
PREV CLOSE
61.44
HIGH
62.39
LOW
58.12
VOLUME
483.83K
TURNOVER
--
52 WEEK HIGH
105.00
52 WEEK LOW
28.40
MARKET CAP
408.56M
P/E (TTM)
-32.9515
1D
5D
1M
3M
1Y
5Y
1D
Monopar Therapeutics GAAP EPS of -$0.46 beats by $0.36
Seeking Alpha · 2h ago
Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics (AQST), Monopar Therapeutics Inc (MNPR)
TipRanks · 10h ago
MONOPAR THERAPEUTICS INC - ON TRACK TO SUBMIT NDA TO FDA IN MID-2026
Reuters · 13h ago
*Monopar Therapeutics 1Q Loss/Shr 46c >MNPR
Dow Jones · 13h ago
Press Release: Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
Dow Jones · 13h ago
Weekly Report: what happened at MNPR last week (0504-0508)?
Weekly Report · 3d ago
Weekly Report: what happened at MNPR last week (0427-0501)?
Weekly Report · 05/04 10:32
Weekly Report: what happened at MNPR last week (0420-0424)?
Weekly Report · 04/27 10:36
More
About MNPR
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.

Webull offers Monopar Therapeutics Inc stock information, including NASDAQ: MNPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MNPR stock methods without spending real money on the virtual paper trading platform.